Mycoplasma Testing Market

The mycoplasma is a bacterium that lacks cell wall and cannot perform metabolism, synthesis of nucleotides or amino acids. The contamination of cell culture with mycoplasma leads to alteration in the cellular functions. As the bacterium is smallest and simplest self-replicating organism, it multiplies rapidly without being noticed through naked eyes and light microscopy, and thus require specific testing methods.

Moreover, contamination with mycoplasma can damage the cell culture significantly leading to alteration in metabolite formations and development of toxins. Thus, the mycoplasma testing plays a vital role in cell culture harvesting and in the manufacturing of biopharmaceuticals. Rising demand from biotechnology and pharmaceutical manufacturing, increasing research & development, and rising investment in biopharmaceutical manufacturing are expected to compliment the growth of mycoplasma testing market during forecast period.

North America contributed the largest share to the global mycoplasma testing market in 2019 and is anticipated to be the dominating geography throughout the forecast period. Increasing investment in research & development of biopharmaceutical & biomedicines and stable pharmaceutical manufacturing industry would be the major growth contributors throughout the forecast period.

Asia Pacific is anticipated to be the fastest growing market segment owing to expanding pharmaceutical manufacturing industry in India, China and Southeast Asia. Global manufacturers are focusing on establishing the research & development centers in India and China, which is anticipated to fuel the growth of mycoplasma testing market in Asia Pacific.

The report titled “Mycoplasma Testing Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global mycoplasma testing market.

Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Thermo Fisher Scientific reported revenues of USD 24.4 billion in 2018 and the product segment analysis of the company indicates that Consumables business segment of the company dominated revenue in 2018.

The global mycoplasma testing market is segmented based on product type, technology, application, end user, and geography. Based on product type, the global mycoplasma testing market is segmented into instruments, kits & reagents, and others. The kits & reagents is further sub-segmented into PCR assays, nucleic acid detection kits, stains, elimination kits, standards & controls, and others. Based on technology, the global mycoplasma testing market is segmented into polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), direct assay, indirect assay, microbial culture techniques, enzymatic methods, and others. Based on application, the global mycoplasma testing market is segmented into cell line testing, virus testing, end of production cells testing, and others. Based on end user, the global mycoplasma testing market is segmented into academic research institutes, cell banks, contract research organizations, pharmaceutical & biotechnology companies, and others. Based on geography, the global mycoplasma testing market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

The research would provide in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on mycoplasma testing. Market share of prominent companies in the global mycoplasma testing market would be included. For instance, Thermo Fisher Scientific operates through three product segments namely Consumables, Instruments, Equipment & Software, and services. The mycoplasma testing products are delivered under Instruments, Equipment & Software business segment of the company with revenue contribution of US$ 6.34 billion in 2018. 

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the mycoplasma testing companies. Furthermore, the global mycoplasma testing market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.

Product portfolio would focus on all the products under the mycoplasma testing market business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global mycoplasma testing market.

Major players active in the global mycoplasma testing market include American Type Culture Collection (ATCC), Biological Industries Israel Beit Haemek Ltd., Bionique Testing Laboratories, Inc., Charles River Laboratories International, Inc., InvivoGen, Lonza Group Ltd., Merck KGaA, PromoCell GmbH, and Thermo Fisher Scientific.

Market Segmentation:

By Product

• Instruments
• Kits & Reagents
  • PCR Assays
  • Nucleic Acid Detection Kits
  • Stains
  • Elimination Kits
  • Standards & Controls
  • Others
• Others

By Technology

• PCR
• ELISA
• Direct Assay
• Indirect Assay
• Microbial Culture Techniques
• Enzymatic Methods

By Application

• Cell Line Testing
• Virus Testing
• End of Production Cells Testing
• Others

By End Use

• Academic Research Institutes
• Cell Banks
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Others

By Geography:

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • India
  • China
  • Australia
  • Rest of Asia Pacific
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
• South America
  • Brazil
  • Rest of South America